Provenance Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Provenance Wealth Advisors's PFE Position: Q3 2026 in Review
Provenance Wealth Advisors increased its Pfizer (PFE) stake by 132% in Q3 2026, buying an estimated $601K and bringing the position to 39,699 shares worth $1.13M. The position accounts for 0.07% of the portfolio, ranked #145.
Provenance Wealth Advisors first reported a position in PFE in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.67M in Q3 2024. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Provenance Wealth Advisors held 39,699 shares of Pfizer worth $1.13M as of Q3 2026.
- Provenance Wealth Advisors bought 22,615 Pfizer shares in Q3 2026, an estimated $601K.
- Pfizer made up 0.07% of Provenance Wealth Advisors's portfolio in Q3 2026, its #145 holding.
- Provenance Wealth Advisors first reported a position in Pfizer in Q3 2023 and has held it in 13 quarters since.
- Provenance Wealth Advisors's Pfizer position peaked at $1.67M in Q3 2024.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Provenance Wealth Advisors's 13F filing for Q3 2026, filed 30 Oct 2026.